FINANCING · 18 SEPTEMBER 2026
Spire Healthcare: when financing becomes part of the deal
The proposed c.£1bn transaction shows why acquisition finance can be as important to understanding a deal as the purchase agreement itself.
×
SPIRE HEALTHCARE · MEDICLINIC
Spire Healthcare has become a useful example of the interaction between M&A and financing. Slaughter and May says it is advising Song Capital on financing the acquisition of Spire, while also reporting its advice to Mediclinic on the c.£1bn recommended cash offer.
Two documents, one commercial outcome
An acquisition agreement tells us what the buyer is acquiring and what it promises to pay. Financing documents answer a different question: how will the buyer fund that promise? In sponsor-backed transactions, the two workstreams are closely connected.
Why debt changes the analysis
Debt introduces obligations that do not exist in an all-equity acquisition. Interest payments, financial covenants, security and events of default can constrain the buyer after completion. The amount and type of debt can therefore influence how much operational flexibility the new owner has.
Why lawyers need the commercial picture
For finance lawyers, the legal drafting is only useful if it reflects the economics of the transaction. Conditions precedent, representations, undertakings and security arrangements need to work alongside the acquisition timetable. The same is true in reverse: acquisition counsel need to understand the financing conditions that could affect completion.
The bigger lesson
A transaction should be read as a system rather than a collection of separate legal workstreams. Purchase price, funding, conditions and post-completion obligations all interact. That is where legal analysis becomes commercial analysis.
Conditions precedent
Requirements that must be satisfied before a financing or acquisition can complete. They can connect the timetable of the acquisition directly to the availability of funding.
Source: Slaughter and May, Recent Work, 9 September 2026 and 7 September 2026. This article is analysis of publicly reported information and is not investment advice.